BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21757320)

  • 1. Using a Virtual Classroom environment to describe the attention deficits profile of children with Neurofibromatosis type 1.
    Gilboa Y; Rosenblum S; Fattal-Valevski A; Toledano-Alhadef H; Rizzo AS; Josman N
    Res Dev Disabil; 2011; 32(6):2608-13. PubMed ID: 21757320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of Conners' Rating Scales-Revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence.
    Deb S; Dhaliwal AJ; Roy M
    J Intellect Disabil Res; 2008 Nov; 52(11):950-65. PubMed ID: 18179511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
    Payne JM; Arnold SS; Pride NA; North KN
    Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Describing the attention profile of children and adolescents with acquired brain injury using the Virtual Classroom.
    Gilboa Y; Kerrouche B; Longaud-Vales A; Kieffer V; Tiberghien A; Aligon D; Mariller A; Mintegui A; Canizares C; Abada G; Paule Chevignard M
    Brain Inj; 2015; 29(13-14):1691-700. PubMed ID: 26399584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of inattention, impulsivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder.
    Halperin JM; Matier K; Bedi G; Sharma V; Newcorn JH
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):190-6. PubMed ID: 1564018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-inserted foreign body and attention-deficit/hyperactivity disorder: evaluated by the Conners' Parent Rating Scales-Revised.
    Özcan K; Özcan Ö; Muluk NB; Cingi C; Durukan K
    Int J Pediatr Otorhinolaryngol; 2013 Dec; 77(12):1992-7. PubMed ID: 24139587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The self-concept of children and adolescents with neurofibromatosis type 1.
    Barton B; North K
    Child Care Health Dev; 2007 Jul; 33(4):401-8. PubMed ID: 17584395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and motor control in neurofibromatosis type I: influence of maturation and hyperactivity-inattention.
    Huijbregts S; Swaab H; de Sonneville L
    Dev Neuropsychol; 2010; 35(6):737-51. PubMed ID: 21038163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled clinical comparison of attention performance in children with ADHD in a virtual reality classroom compared to standard neuropsychological methods.
    Parsons TD; Bowerly T; Buckwalter JG; Rizzo AA
    Child Neuropsychol; 2007 Jul; 13(4):363-81. PubMed ID: 17564852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology.
    Larsson H; Dilshad R; Lichtenstein P; Barker ED
    J Child Psychol Psychiatry; 2011 Sep; 52(9):954-63. PubMed ID: 21434915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early grade repetition and inattention associated with neurofibromatosis type 1.
    Coudé FX; Mignot C; Lyonnet S; Munnich A
    J Atten Disord; 2007 Sep; 11(2):101-5. PubMed ID: 17494836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
    Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
    Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved behavior and sleep after adenotonsillectomy in children with sleep-disordered breathing.
    Wei JL; Mayo MS; Smith HJ; Reese M; Weatherly RA
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):974-9. PubMed ID: 17938319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms of inattention and hyperactivity in children with habitual snoring: evidence from a community-based study in Istanbul.
    Arman AR; Ersu R; Save D; Karadag B; Karaman G; Karabekiroglu K; Karakoc F; Dagli E; Berkem M
    Child Care Health Dev; 2005 Nov; 31(6):707-17. PubMed ID: 16207229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distractibility in Attention/Deficit/ Hyperactivity Disorder (ADHD): the virtual reality classroom.
    Adams R; Finn P; Moes E; Flannery K; Rizzo AS
    Child Neuropsychol; 2009 Mar; 15(2):120-35. PubMed ID: 18608217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior.
    Payne JM; Hyman SL; Shores EA; North KN
    Child Neuropsychol; 2011; 17(4):313-29. PubMed ID: 21347908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
    Hyman SL; Arthur Shores E; North KN
    Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.